- What is M&S? – “Modeling & Simulation”
- M&S Decisions LLC is an independent modeling consultancy, founded in May 2015
- Our team consists of 15 modeling scientists with core scientific expertise in the systems pharmacology and pharmacometrics.
- Via model-based knowledge integration M&S Decisions address recurring questions on compound selection, dose & dose scheduling, therapeutic window, adequate patient populations, optimized study design
- Our objective is to provide Model-informed Drug Development (MIDD) solutions: scientific, quantitative information and models, to support decision-making in R&D translational and clinical projects
- The depth and breadth of modeling skills represented within M&S Decisions allow us to cover: population PKPD and pharmacometrics, quantitative systems pharmacology (QSP), disease progression modeling, meta-analyses – thereby providing our clients with quantitative companion tools, in support of decision-making across the Drug R&D continuum.
- M&S Decisions provides modeling services for the global pharmaceutical companies and biomedical start-ups.
- Starting December 2015 M&S Decisions has granted residency status of Skolkovo innovation hub